Innovacell (TSE:504A) Selling, General, & Admin. Expense: 円492.69 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:504A Innovacell Inc TSE:504A
10 GF Score
Price 円583.00
View Full Analysis

What is Innovacell Selling, General, & Admin. Expense?

Innovacell TSE:504A +7.56% 10 Selling, General, & Admin. Expense is 円492.69 Mil as of Jun. 2026. GuruFocus rates TSE:504A with a GF Score™ of 10/100.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Innovacell's selling, general, & admin. expense for the three months ended in Jun. 2026 was 円0.00 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jun. 2026 was 円492.69 Mil.


Innovacell  (TSE:504A) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Innovacell Selling, General, & Admin. Expense Related Terms


Innovacell Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Innovacell's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovacell Selling, General, & Admin. Expense Chart

Innovacell Annual Data
Trend Dec23 Dec24 Dec25
Selling, General, & Admin. Expense
511.46 487.13 544.41

Innovacell Quarterly Data
Dec23 Dec24 Sep25 Dec25 Mar26 Jun26
Selling, General, & Admin. Expense Get a 7-Day Free Trial 0.00 147.20 139.14 206.35 0.00

TSE:504A vs VRTX, REGN, MRNA: Selling, General, & Admin. Expense Comparison

For the Biotechnology subindustry, Innovacell's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovacell Selling, General, & Admin. Expense vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovacell's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Innovacell's Selling, General, & Admin. Expense falls into.


TSE:504A
10GF Score
Innovacell Inc TSE:504A
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovacell Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円492.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of 円492.69 Mil mean?
Innovacell (TSE:504A) has a Selling, General, & Admin. Expense of 円492.69 Mil as of Jun. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Innovacell and its competitors.
Is Innovacell's Selling, General, & Admin. Expense too high?
Innovacell's current Selling, General, & Admin. Expense is 円492.69 Mil. Overall, Innovacell has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Innovacell's Selling, General, & Admin. Expense compare to VRTX and REGN?
Innovacell's Selling, General, & Admin. Expense of 円492.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Biotechnology company?
A good Selling, General, & Admin. Expense depends on the Biotechnology industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Innovacell and its competitors. Innovacell's current Selling, General, & Admin. Expense is 円492.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovacell stock overvalued right now?
Innovacell (TSE:504A) has a current Selling, General, & Admin. Expense of 円492.69 Mil. The current Selling, General, & Admin. Expense is 円492.69 Mil. Innovacell's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Innovacell (TSE:504A), the current Selling, General, & Admin. Expense is 円492.69 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovacell Business Description

Address 3-5-11 Kamiosaki, Meguro Villa Garden, 5th floor, Shinagawa-ku, Tokyo, JPN, 141-0021
Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatment of conditions including fecal and urinary incontinence. Its activities include researching potential therapeutic candidates, developing formulations, and commercializing products in the markets. The company is working on the development and commercialization of the following three cell therapy pipelines targeting incontinence (fecal and urinary incontinence): ICEF15, ICEF16, and ICES13.
10GF Score

Get the complete analysis for TSE:504A

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円583.00
Price